Le Lézard
Classified in: Health
Subject: SVY

United States Peripheral Vascular Stent Market Report 2018


DUBLIN, June 20, 2018 /PRNewswire/ --

The "Peripheral Vascular Stent Market | US | Units Sold, Average Selling Prices, Forecasts | 2018-2024| MedCore" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

There will be an increase in peripheral stenting procedure numbers, which is driven by the aging population. As the U.S. population enters the age where they are at greater risk for peripheral arterial disease, the demand for stents will increase. Because stent procedures are minimally invasive, they are free of many of the complications associated with surgery; therefore, physicians are more inclined to recommend the use of the devices.


Key Topics Covered:



Executive Summary
U.S. Peripheral Vascular Device Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History

1. Research Methodology

2. Disease Overview
2.1 Basic Anatomy
2.2 Disease Overview
2.2.1 Aortic Aneurysms
2.2.2 Atherosclerosis
2.2.3 Peripheral Arterial Disease (Pad)
2.2.4 Deep Vein Thrombosis (Dvt)
2.2.5 Pulmonary Embolism (Pe)
2.3 Patient Demographics
2.3.1 Aortic Aneurysms
2.3.2 Atherosclerosis
2.3.3 Peripheral Arterial Disease (Pad)
2.3.4 Deep Vein Thrombosis (Dvt)
2.3.5 Pulmonary Embolism (Pe)

3. Peripheral Vascular Stent Market
3.1 Introduction
3.1.1 Off-Label Use
3.1.2 Covered Stents
3.1.3 Drug-Eluting Peripheral Vascular Stents
3.1.4 Infrapopliteal Stenting
3.1.5 Stent Length
3.1.6 General Information
3.2 Market Overview
3.3 Market Analysis And Forecast
3.3.1 Bare-Metal Stent Market
3.3.1.1 Total Bare-Metal Stent Market
3.3.1.2 Bare-Metal Stent Market By Indication
3.3.1.3 Bare-Metal Stent Market By Delivery Platform
3.3.2 Covered Stent Market
3.3.2.1 Iliac Covered Stent Market
3.3.2.2 Fem-Pop Covered Stent Market
3.3.2.3 Av Access Covered Stent Market
3.3.3 Total Drug-Eluting Stent Market
3.3.3.1 Sfa Drug-Eluting Stent Market
3.3.3.2 Infra-Popliteal Drug-Eluting Stent Market
3.4 Unit Analysis
3.4.1 Units Sold By Stent Length
3.4.1.1 Bare-Metal Carotid Stent Units
3.4.1.2 Bare-Metal Renal Stent Units
3.4.1.3 Bare-Metal Iliac Stent Units
3.4.1.4 Bare-Metal Fem-Popliteal Stent Units
3.5 Drivers And Limiters
3.6 Competitive Market Share Analysis
3.6.1 Total Peripheral Vascular Stent Market
3.6.2 Bare-Metal Stent Market By Indication
3.6.2.1 Iliac
3.6.2.2 Carotid
3.6.2.3 Renal
3.6.2.4 Femoral-Popliteal
3.6.2.5 Infra-Popliteal
3.6.3 Bare-Metal Stent Market By Delivery Platform
3.6.4 Drug-Eluting Stent Market By Indication
3.6.4.1 Sfa Drug-Eluting Stent Market
3.6.4.2 Infra-Popliteal Drug-Eluting Stent Market

4. Abbreviations

5. Appendix: Company Press Releases

For more information about this report visit https://www.researchandmarkets.com/research/rgz7v7/united_states?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:


Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



SOURCE Research and Markets


These press releases may also interest you

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

24 avr 2024
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

24 avr 2024
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

24 avr 2024
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral...



News published on and distributed by: